支持蛹虫草和三七复方抗癌草药配方的最佳案例系列项目。
Best case series program supportive cases of Cordyceps militaris- and panax notoginseng-based anticancer herbal formula.
机构信息
East-West Cancer Center, Daejeon University, Daejeon, Korea.
出版信息
Integr Cancer Ther. 2011 Dec;10(4):NP1-3. doi: 10.1177/1534735411423921. Epub 2011 Oct 11.
OBJECTIVE
The major aim of this study was to present 2 cancer cases treated with anticancer herbal formula Panax notoginseng and Cordyceps militaris.
METHODS
Two patients, with pancreatic adenocarcinoma and mucosa-associated lymphatic tissue type lymphoma, respectively, were treated with P notoginseng and C militaris herbal formula without conventional treatments. Their tumor masses were compared using computed tomography during early and later periods of herbal formula treatment.
RESULTS
On computed tomography, reduction in tumor mass in both patients after 17 and 13 months of herbal treatments was noted, and the patients maintained stable disease and good quality of life until the last contact in November 2008.
CONCLUSION
C militaris and P notoginseng are potential anticancer herbal prescriptions for adenocarcinoma and mucosa-associated lymphatic tissue type lymphoma.
目的
本研究的主要目的是介绍两例使用抗癌中草药配方三七和蛹虫草治疗的癌症病例。
方法
两名患者分别患有胰腺腺癌和黏膜相关淋巴组织型淋巴瘤，未接受常规治疗，仅使用三七和蛹虫草中草药配方进行治疗。在中草药治疗的早期和后期，通过计算机断层扫描对他们的肿瘤进行比较。
结果
在计算机断层扫描中，两名患者在接受草药治疗 17 个月和 13 个月后，肿瘤体积均有缩小，且患者在 2008 年 11 月最后一次联系时，疾病稳定，生活质量良好。
结论
蛹虫草和三七可能是治疗腺癌和黏膜相关淋巴组织型淋巴瘤的潜在抗癌中草药方剂。
Zotero 插件